Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Xuechao Wu, Quan Wan, Jing Wang, Peng Hou, Qijian Zhang, Qing Wang & Xiaojie Lu. (2022) Epigenetic Activation of lncRNA MIR155HG Mediated by Promoter Hypomethylation and SP1 is Correlated with Immune Infiltration in Glioma. OncoTargets and Therapy 15, pages 219-235.
Read now
Read now
Mehrdad Fathi, Seyed-Mostafa Razavi, Mozhdeh Sojoodi, Armin Ahmadi, Farbod Ebrahimi, Afshin Namdar, Mohammad Hojjat-Farsangi, Sharareh Gholamin & Farhad Jadidi-Niaragh. (2022) Targeting the CTLA-4/B7 axes in glioblastoma: preclinical evidence and clinical interventions. Expert Opinion on Therapeutic Targets 26:11, pages 949-961.
Read now
Read now
Patrick C. Gedeon, Cosette D. Champion, Kristen E. Rhodin, Karolina Woroniecka, Hanna R. Kemeny, Alexa N. Bramall, Joshua D. Bernstock, Bryan D. Choi & John H. Sampson. (2020) Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook. Expert Review of Clinical Pharmacology 13:10, pages 1147-1158.
Read now
Read now
Steven H. Shen, Karolina Woroniecka, Andrew B. Barbour, Peter E. Fecci, Luis Sanchez-Perez & John H. Sampson. (2020) CAR T cells and checkpoint inhibition for the treatment of glioblastoma. Expert Opinion on Biological Therapy 20:6, pages 579-591.
Read now
Read now
Nazanin Majd & John de Groot. (2019) Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma. Expert Opinion on Pharmacotherapy 20:13, pages 1609-1624.
Read now
Read now
Articles from other publishers (78)
Ali Ghasemi, Amaia Martinez-Usatorre, Luqing Li, Mehdi Hicham, Alan Guichard, Rachel Marcone, Nadine Fournier, Bruno Torchia, Darel Martinez Bedoya, Suzel Davanture, Mirian Fernández-Vaquero, Chaofan Fan, Jakob Janzen, Yahya Mohammadzadeh, Raphael Genolet, Nahal Mansouri, Mathias Wenes, Denis Migliorini, Mathias Heikenwalder & Michele De Palma. (2023) Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy. Nature Cancer.
Crossref
Crossref
Hasan Slika, Ziya Karimov, Paolo Alimonti, Tatiana Abou-Mrad, Emerson De Fazio, Safwan Alomari & Betty Tyler. (2023) Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues. International Journal of Molecular Sciences 24:22, pages 16316.
Crossref
Crossref
Fuming Liang, Qing You, Xiaopeng Ma, Huayi Wang, Chen Wang, Zhaohui He, Yanlian Yang & Ling Zhu. (2023) Nano-imaging agents for brain diseases: Environmentally responsive imaging and therapy. Nano Research.
Crossref
Crossref
Laura M. Bartos, Sabrina V. Kirchleitner, Zeynep Ilgin Kolabas, Stefanie Quach, Alexander Beck, Julia Lorenz, Jens BlobnerStephan A. Mueller, Selin Ulukaya, Luciano HoeherIzabela Horvath, Karin Wind-Mark, Adrien Holzgreve, Viktoria C. Ruf, Lukas Gold, Lea H. Kunze, Sebastian T. KuntePhilipp BeumersHa Eun Park, Melissa Antons, Artem Zatcepin, Nils Briel, Leonie HoermannRebecca Schaefer, Denise MessererPeter BartensteinMarkus J. RiemenschneiderSimon Lindner, Sibylle ZieglerJochen HermsStefan F. Lichtenthaler, Ali ErtürkJoerg C. Tonn, Louisa von BaumgartenNathalie L. Albert & Matthias Brendel. (2023) Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution. Science Advances 9:43.
Crossref
Crossref
Wenqiang Zhang, Kexin Zhang, Yanhui Ma, Yixin Song, Tongbing Qi, Guoji Xiong, Yuanzhu Zhang, Chengxia Kan, Jingwen Zhang, Fang Han & Xiaodong Sun. (2023) Secreted frizzled-related proteins: A promising therapeutic target for cancer therapy through Wnt signaling inhibition. Biomedicine & Pharmacotherapy 166, pages 115344.
Crossref
Crossref
Qi Wang & Zhe Wang. (2023) Serpin family H member 1 and its related collagen gene network are the potential prognostic biomarkers and anticancer targets for glioma. Journal of Biochemical and Molecular Toxicology.
Crossref
Crossref
Mélodie Davy, Laurie Genest, Christophe Legrand, Océane Pelouin, Guillaume Froget, Vincent Castagné & Tristan Rupp. (2023) Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models. Cancers 15:18, pages 4478.
Crossref
Crossref
Juyeun Lee, Michael Nicosia, Ellen S. Hong, Daniel J. Silver, Cathy Li, Defne Bayik, Dionysios C. Watson, Adam Lauko, Kristen E. Kay, Sabrina Z. Wang, Sadie Johnson, Mary McGraw, Matthew M. Grabowski, Danielle D. Kish, Amar B. Desai, Wendy A. Goodman, Scott J. Cameron, Hideho Okada, Anna Valujskikh, Robert L. Fairchild, Manmeet S. Ahluwalia & Justin D. Lathia. (2023) Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma. Cancer Discovery 13:9, pages 2090-2105.
Crossref
Crossref
Dan Chen, Siva Karthik Varanasi, Toshiro Hara, Kacie Traina, Ming Sun, Bryan McDonald, Yagmur Farsakoglu, Josh Clanton, Shihao Xu, Lizmarie Garcia-Rivera, Thomas H. Mann, Victor Du, H. Kay Chung, Ziyan Xu, Victoria Tripple, Eduardo Casillas, Shixin Ma, Carolyn O’Connor, Qiyuan Yang, Ye Zheng, Tony Hunter, Greg Lemke & Susan M. Kaech. (2023) CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma. Immunity 56:9, pages 2086-2104.e8.
Crossref
Crossref
Chao-Hsien Chen, Renee L Chin, Genevieve P Hartley, Spencer T Lea, Brian J Engel, Cheng-En Hsieh, Rishika Prasad, Jason Roszik, Takashi Shingu, Gregory A Lizee, Amy B Heimberger, Steven W Millward, Jian Hu, David S Hong & Michael A Curran. (2023) Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease. Neuro-Oncology 25:8, pages 1415-1427.
Crossref
Crossref
Isha Mondal, Oishika Das, Raymond Sun, Jian Gao, Bohyeon Yu, Aaron Diaz, Jinan Behnan, Abhishek Dubey, Zhipeng Meng, Emad Eskandar, Beisi Xu, Rongze Olivia Lu & Winson S. Ho. (2023) PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma. Cancer Research 83:15, pages 2527-2542.
Crossref
Crossref
Fei Sun, Hongtao Lv, Baozhi Feng, Jiaao Sun, Linyun Zhang & Bin Dong. (2023) Identification of natural killer cell-related characteristics to predict the clinical prognosis and immune microenvironment of patients with low-grade glioma. Aging 15:13, pages 6264-6291.
Crossref
Crossref
Michal Nisnboym, Sarah R. Vincze, Zujian Xiong, Chaim T. Sneiderman, Rebecca A. Raphael, Bo Li, Ambika P. Jaswal, ReidAnn E. Sever, Kathryn E. Day, Joseph D. LaToche, Lesley M. Foley, Hanieh Karimi, T. Kevin Hitchens, Sameer Agnihotri, Baoli Hu, Dhivyaa Rajasundaram, Carolyn J. Anderson, Deborah T. Blumenthal, Thomas M. Pearce, Shikhar Uttam, Jessie R. Nedrow, Ashok Panigrahy, Ian F. Pollack, Frank S. Lieberman, Jan Drappatz, Itay Raphael, Wilson B. Edwards & Gary Kohanbash. (2023) Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma. Cancer Research Communications 3:7, pages 1173-1188.
Crossref
Crossref
Amelia Foss & Manav Pathania. (2023) Pediatric Glioma Models Provide Insights into Tumor Development and Future Therapeutic Strategies. Developmental Neuroscience, pages 1-22.
Crossref
Crossref
Colin McCornack, Timothy Woodiwiss, Angela Hardi, Hiroko Yano & Albert H. Kim. (2023) The function of histone methylation and acetylation regulators in GBM pathophysiology. Frontiers in Oncology 13.
Crossref
Crossref
Luuk van Hooren, Shanna M. Handgraaf, Daan J. Kloosterman, Elham Karimi, Lotte W.H.G. van Mil, Awa A. Gassama, Beatriz Gomez Solsona, Marnix H. P. de Groot, Dieta Brandsma, Daniela F. Quail, Logan A. Walsh, Gerben R. Borst & Leila Akkari. (2023) CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma. Nature Cancer 4:5, pages 665-681.
Crossref
Crossref
Sukrit Mahajan, Mirko H. H. Schmidt & Ulrike Schumann. (2023) The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens. Cancers 15:7, pages 2024.
Crossref
Crossref
Winson S. Ho, Isha Mondal, Beisi Xu, Oishika Das, Raymond Sun, Pochin Chiou, Xiaomin Cai, Foozhan Tahmasebinia, Elizabeth McFadden, Caren Yu-Ju Wu, Zhihao Wu, William Matsui, Michael Lim, Zhipeng Meng & Rongze Olivia Lu. (2023) PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages. Journal of Clinical Investigation 133:6.
Crossref
Crossref
Stephen C. Frederico, Xiaoran Zhang, Baoli Hu & Gary Kohanbash. (2023) Pre-clinical models for evaluating glioma targeted immunotherapies. Frontiers in Immunology 13.
Crossref
Crossref
Lin Ma, Alba Gonzalez-Junca, William Chou & Mary Helen Barcellos-Hoff. 2023. Radiation Oncology and Radiotherapy Part C. Radiation Oncology and Radiotherapy Part C
49
67
.
Angelique Sao-Mai S. Tay, Keith L. Black & John S. Yu. 2023. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1
51
72
.
Mathilde Bausart, Véronique Préat & Alessio Malfanti. (2022) Immunotherapy for glioblastoma: the promise of combination strategies. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Defne Bayik, Cynthia F. Bartels, Katreya Lovrenert, Dionysios C. Watson, Duo Zhang, Kristen Kay, Juyeun Lee, Adam Lauko, Sadie Johnson, Alice Lo, Daniel J. Silver, Mary McGraw, Matthew Grabowski, Alireza M. Mohammadi, Filippo Veglia, Yi Fan, Michael A. Vogelbaum, Peter Scacheri & Justin D. Lathia. (2022) Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets. Cancer Research 82:22, pages 4274-4287.
Crossref
Crossref
Karolina Žilionytė, Ugnė Bagdzevičiūtė, Agata Mlynska, Elena Urbštaitė, Emilija Paberalė, Neringa Dobrovolskienė, Jan Aleksander Krasko & Vita Pašukonienė. (2022) Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models. Cancer Immunology, Immunotherapy 71:11, pages 2691-2700.
Crossref
Crossref
Laura M. Bartos, Sabrina V. Kirchleitner, Jens Blobner, Karin Wind, Lea H. Kunze, Adrien Holzgreve, Lukas Gold, Artem Zatcepin, Zeynep Ilgin Kolabas, Selin Ulukaya, Lorraine Weidner, Stefanie Quach, Denise Messerer, Peter Bartenstein, Joerg C. Tonn, Markus J. Riemenschneider, Sibylle Ziegler, Louisa von Baumgarten, Nathalie L. Albert & Matthias Brendel. (2022) 18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model. Frontiers in Medicine 9.
Crossref
Crossref
Mohsen Karami Fath, Kimiya Babakhaniyan, Mehran Anjomrooz, Mohammadrasoul Jalalifar, Seyed Danial Alizadeh, Zeinab Pourghasem, Parisa Abbasi Oshagh, Ali Azargoonjahromi, Faezeh Almasi, Hafza Zahira Manzoor, Bahman Khalesi, Navid Pourzardosht, Saeed Khalili & Zahra Payandeh. (2022) Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms. Vaccines 10:9, pages 1448.
Crossref
Crossref
Sascha Marx, Anze Godicelj & Kai W. Wucherpfennig. (2022) A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma. Seminars in Immunopathology 44:5, pages 697-707.
Crossref
Crossref
Yingping Zeng, Sufen Li, Shufen Zhang, Li Wang, Hong Yuan & Fuqiang Hu. (2022) Cell membrane coated-nanoparticles for cancer immunotherapy. Acta Pharmaceutica Sinica B 12:8, pages 3233-3254.
Crossref
Crossref
Gilles Berger, Erik H. Knelson, Jorge L. Jimenez-Macias, Michal O. Nowicki, Saemi Han, Eleni Panagioti, Patrick H. Lizotte, Kwasi Adu-Berchie, Alexander Stafford, Nikolaos Dimitrakakis, Lanlan Zhou, E. Antonio Chiocca, David J. Mooney, David A. Barbie & Sean E. Lawler. (2022) STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models. Proceedings of the National Academy of Sciences 119:28.
Crossref
Crossref
Daniel B. Zamler, Takashi Shingu, Laura M. Kahn, Kristin Huntoon, Cynthia Kassab, Martina Ott, Katarzyna Tomczak, Jintan Liu, Yating Li, Ivy Lai, Rocio Zorilla-Veloz, Cassian Yee, Kunal Rai, Betty Y.S. Kim, Stephanie S. Watowich, Amy B. Heimberger, Giulio F. Draetta & Jian Hu. (2022) Immune landscape of a genetically engineered murine model of glioma compared with human glioma. JCI Insight 7:12.
Crossref
Crossref
Mathilde Bausart, Kevin Vanvarenberg, Bernard Ucakar, Alessandra Lopes, Gaëlle Vandermeulen, Alessio Malfanti & Véronique Préat. (2022) Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model. Pharmaceutics 14:5, pages 1025.
Crossref
Crossref
Masoud Farshbaf, Solmaz Mojarad-Jabali, Salar Hemmati, Ahmad Yari Khosroushahi, Hamidreza Motasadizadeh, Amir Zarebkohan & Hadi Valizadeh. (2022) Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers. Journal of Controlled Release 345, pages 371-384.
Crossref
Crossref
Ana Paula Candiota & Carles Arús. (2022) Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives. Metabolites 12:3, pages 243.
Crossref
Crossref
Johannes K. Andersen, Hrvoje Miletic & Jubayer A. Hossain. (2022) Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities. Cancers 14:5, pages 1319.
Crossref
Crossref
Vijay Letchuman, Leonel Ampie, Ashish H. Shah, Desmond A. Brown, John D. Heiss & Prashant Chittiboina. (2022) Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes. Neurosurgical Focus 52:2, pages E5.
Crossref
Crossref
Pavlina Chuntova, Yafei Hou, Ryosuke Naka, Akane Yamamichi, Tiffany Chen, Yitzhar Goretsky, Ryusuke Hatae, Takahide Nejo, Gary Kohanbash, Abigail L Mende, Megan Montoya, Kira M Downey, David Diebold, Jayne Skinner, Hong-Erh Liang, Bjoern Schwer & Hideho Okada. (2022) Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. Neuro-Oncology 24:2, pages 259-272.
Crossref
Crossref
Upasana Sahu, Rolf F Barth, Yoshihiro Otani, Ryan McCormack & Balveen Kaur. (2022) Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research. Journal of Neuropathology & Experimental Neurology 81:5, pages 312-329.
Crossref
Crossref
Anders Handrup Kverneland, Christopher Aled Chamberlain, Troels Holz Borch, Morten Nielsen, Sofie Kirial Mørk, Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Lise Pyndt Jørgensen, Lene Buhl Riis, Christina Westmose Yde, Özcan Met, Marco Donia & Inge Marie Svane. (2021) Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types. Journal for ImmunoTherapy of Cancer 9:10, pages e003499.
Crossref
Crossref
Vassilis Genoud, Felipe I. Espinoza, Eliana Marinari, Viviane Rochemont, Pierre-Yves Dietrich, Paul McSheehy, Felix Bachmann, Heidi A. Lane & Paul R. Walker. (2021) Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin). JCI Insight 6:18.
Crossref
Crossref
Breanna Noffsinger, Alexandra Witter, Natasha Sheybani, Aizhen Xiao, Laryssa Manigat, Qing Zhong, Suchet Taori, Tajie Harris, Tim Bullock, Richard Price & Benjamin Purow. (2021) Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner. Journal of Neuro-Oncology 154:2, pages 145-157.
Crossref
Crossref
Apeng Chen, Yinan Jiang, Zhengwei Li, Lingxiang Wu, Ulises Santiago, Han Zou, Chunhui Cai, Vaibhav Sharma, Yongchang Guan, Lauren H. McCarl, Jie Ma, Yijen L. Wu, Joshua Michel, Yi Shi, Liza Konnikova, Nduka M. Amankulor, Pascal O. Zinn, Gary Kohanbash, Sameer Agnihotri, Songjian Lu, Xinghua Lu, Dandan Sun, George K. Gittes, Qianghu Wang, Xiangwei Xiao, Dean Yimlamai, Ian F. Pollack, Carlos J. Camacho & Baoli Hu. (2021) Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma. Journal of Clinical Investigation 131:16.
Crossref
Crossref
Rachel L. Y. Ho & Ivy A. W. Ho. (2021) Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade. Cancers 13:15, pages 3686.
Crossref
Crossref
Maria B. Garcia-Fabiani, Santiago Haase, Andrea Comba, Stephen Carney, Brandon McClellan, Kaushik Banerjee, Mahmoud S. Alghamri, Faisal Syed, Padma Kadiyala, Felipe J. Nunez, Marianela Candolfi, Antonela Asad, Nazareno Gonzalez, Marisa E. Aikins, Anna Schwendeman, James J. Moon, Pedro R. Lowenstein & Maria G. Castro. (2021) Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies. Frontiers in Oncology 11.
Crossref
Crossref
Erin F Simonds, Edbert D Lu, Oscar Badillo, Shokoufeh Karimi, Eric V Liu, Whitney Tamaki, Chiara Rancan, Kira M Downey, Jacob Stultz, Meenal Sinha, Lauren K McHenry, Nicole M Nasholm, Pavlina Chuntova, Anders Sundström, Vassilis Genoud, Shilpa A Shahani, Leo D Wang, Christine E Brown, Paul R Walker, Fredrik J Swartling, Lawrence Fong, Hideho Okada, William A Weiss & Mats Hellström. (2021) Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. Journal for ImmunoTherapy of Cancer 9:6, pages e002181.
Crossref
Crossref
Miika Martikainen, Mohanraj Ramachandran, Roberta Lugano, Jing Ma, Minttu-Maria Martikainen, Anna Dimberg, Di Yu, Andres Merits & Magnus Essand. (2021) IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma. Molecular Therapy - Oncolytics 21, pages 37-46.
Crossref
Crossref
Pilar Calero-Pérez, Shuang Wu, Carles Arús & Ana Candiota. (2021) Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses. Cancers 13:11, pages 2663.
Crossref
Crossref
Zohreh Amoozgar, Jonas Kloepper, Jun Ren, Rong En Tay, Samuel W. Kazer, Evgeny Kiner, Shanmugarajan Krishnan, Jessica M. Posada, Mitrajit Ghosh, Emilie Mamessier, Christina Wong, Gino B. Ferraro, Ana Batista, Nancy Wang, Mark Badeaux, Sylvie Roberge, Lei Xu, Peigen Huang, Alex K. Shalek, Dai Fukumura, Hye-Jung Kim & Rakesh K. Jain. (2021) Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nature Communications 12:1.
Crossref
Crossref
Carina Peres, Ana I. Matos, Liane I.F. Moura, Rita C. Acúrcio, Barbara Carreira, Sabina Pozzi, Daniella Vaskovich-Koubi, Ron Kleiner, Ronit Satchi-Fainaro & Helena F. Florindo. (2021) Preclinical models and technologies to advance nanovaccine development. Advanced Drug Delivery Reviews 172, pages 148-182.
Crossref
Crossref
Oluwatosin O. Akintola & David A. Reardon. (2021) The Current Landscape of Immune Checkpoint Blockade in Glioblastoma. Neurosurgery Clinics of North America 32:2, pages 235-248.
Crossref
Crossref
Vassilis Genoud & Denis Migliorini. (2021) Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies. International Journal of Molecular Sciences 22:7, pages 3493.
Crossref
Crossref
Pavlina Chuntova, Frances Chow, Payal B Watchmaker, Mildred Galvez, Amy B Heimberger, Evan W Newell, Aaron Diaz, Ronald A DePinho, Ming O Li, E John Wherry, Duane Mitchell, Masaki Terabe, Derek A Wainwright, Jay A Berzofsky, Christel Herold-Mende, James R Heath, Michael Lim, Kim A Margolin, E Antonio Chiocca, Noriyuki Kasahara, Benjamin M Ellingson, Christine E Brown, Yvonne Chen, Peter E Fecci, David A Reardon, Gavin P Dunn, Linda M Liau, Joseph F Costello, Wolfgang Wick, Timothy Cloughesy, William C Timmer, Patrick Y Wen, Robert M Prins, Michael Platten & Hideho Okada. (2021) Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank. Neuro-Oncology 23:3, pages 356-375.
Crossref
Crossref
Alexander F. Haddad, Jacob S. Young, Nikhil V. Mummaneni, Noriyuki Kasahara & Manish K. Aghi. (2021) Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies. Journal of Neuro-Oncology 152:1, pages 1-13.
Crossref
Crossref
Alexander F. Haddad, Jacob S. Young & Manish K. Aghi. (2021) Using viral vectors to deliver local immunotherapy to glioblastoma. Neurosurgical Focus 50:2, pages E4.
Crossref
Crossref
Alba Gonzalez-Junca, Oliver Reiners, Luis D. Borrero-Garcia, Denis Beckford-Vera, Ann A. Lazar, William Chou, Steve Braunstein, Henry VanBrocklin, Benjamin L. Franc & Mary Helen Barcellos-Hoff. (2021) Positron Emission Tomography Imaging of Functional Transforming Growth Factor β (TGFβ) Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors. International Journal of Radiation Oncology*Biology*Physics 109:2, pages 527-539.
Crossref
Crossref
Sharmila Nair, Luciano Mazzoccoli, Arijita Jash, Jennifer Govero, Sachendra S. Bais, Tong Hu, Camila R. Fontes-Garfias, Chao Shan, Hideho Okada, Sujan Shresta, Jeremy N. Rich, Pei-Yong Shi, Michael S. Diamond & Milan G. Chheda. (2021) Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade. JCI Insight 6:1.
Crossref
Crossref
Alexander F Haddad, Jacob S Young, Dominic Amara, Mitchel S Berger, David R Raleigh, Manish K Aghi & Nicholas A Butowski. (2021) Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neuro-Oncology Advances 3:1.
Crossref
Crossref
Zachariah P Tritz, Katayoun Ayasoufi & Aaron J Johnson. (2021) Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail. Neuro-Oncology Advances 3:1.
Crossref
Crossref
Nazanin K. Majd, Pushan R. Dasgupta & John F. de Groot. 2021. Immunotherapy. Immunotherapy
233
258
.
Roxanne Wouters, Sien Bevers, Matteo Riva, Frederik De Smet & An Coosemans. (2020) Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma. Cancers 13:1, pages 19.
Crossref
Crossref
Eliane Klein, Ann-Christin Hau, Anaïs Oudin, Anna Golebiewska & Simone P. Niclou. (2020) Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy. Frontiers in Oncology 10.
Crossref
Crossref
Fangkun Liu, Jing Huang, Xuming Liu, Quan Cheng, Chengke Luo & Zhixiong Liu. (2020) CTLA-4 correlates with immune and clinical characteristics of glioma. Cancer Cell International 20:1.
Crossref
Crossref
Nicholas F. Brown, Stasya M. Ng, Claire Brooks, Tim Coutts, Jane Holmes, Corran Roberts, Leena Elhussein, Peter Hoskin, Tim Maughan, Sarah Blagden & Paul Mulholland. (2020) A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol. BMC Cancer 20:1.
Crossref
Crossref
Connor J Liu, Maximilian Schaettler, Dylan T Blaha, Jay A Bowman-Kirigin, Dale K Kobayashi, Alexandra J Livingstone, Diane Bender, Christopher A Miller, David M Kranz, Tanner M Johanns & Gavin P Dunn. (2020) Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine. Neuro-Oncology 22:9, pages 1276-1288.
Crossref
Crossref
Megan L Montoya, Noriyuki Kasahara & Hideho Okada. (2020) Introduction to immunotherapy for brain tumor patients: challenges and future perspectives. Neuro-Oncology Practice 7:5, pages 465-476.
Crossref
Crossref
Marta Calvo Tardón, Eliana Marinari, Denis Migliorini, Viviane Bes, Stoyan Tankov, Emily Charrier, Thomas A McKee, Valérie Dutoit, Pierre-Yves Dietrich, Erika Cosset & Paul R Walker. (2020) An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin. Biology 9:9, pages 264.
Crossref
Crossref
Jasneet Kaur Khalsa, Nina Cheng, Joshua Keegan, Ameen Chaudry, Joseph Driver, Wenya Linda Bi, James Lederer & Khalid Shah. (2020) Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types. Nature Communications 11:1.
Crossref
Crossref
Defne Bayik, Yadi Zhou, Chihyun Park, Changjin Hong, Daniel Vail, Daniel J. Silver, Adam Lauko, Gustavo Roversi, Dionysios C. Watson, Alice Lo, Tyler J. Alban, Mary McGraw, Mia Sorensen, Matthew M. Grabowski, Balint Otvos, Michael A. Vogelbaum, Craig Horbinski, Bjarne Winther Kristensen, Ahmad M. Khalil, Tae Hyun Hwang, Manmeet S. Ahluwalia, Feixiong Cheng & Justin D. Lathia. (2020) Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner. Cancer Discovery 10:8, pages 1210-1225.
Crossref
Crossref
Shubhanchi Nigam, Lauren McCarl, Rajeev Kumar, Robert S. Edinger, Brenda F. Kurland, Carolyn J. Anderson, Ashok Panigrahy, Gary Kohanbash & W. Barry Edwards. (2019) Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody. Molecular Imaging and Biology 22:3, pages 685-694.
Crossref
Crossref
Shengchao Xu, Lu Tang, Xizhe Li, Fan Fan & Zhixiong Liu. (2020) Immunotherapy for glioma: Current management and future application. Cancer Letters 476, pages 1-12.
Crossref
Crossref
Yuan Zhou, Weijian Wu, Hongye Bi, Dayong Yang & Chunzhi Zhang. (2020) Glioblastoma precision therapy: From the bench to the clinic. Cancer Letters 475, pages 79-91.
Crossref
Crossref
Shuzhen Tan, Dongpei Li & Xiao Zhu. (2020) Cancer immunotherapy: Pros, cons and beyond. Biomedicine & Pharmacotherapy 124, pages 109821.
Crossref
Crossref
Katrin Aslan, Verena Turco, Jens Blobner, Jana K. Sonner, Anna Rita Liuzzi, Nicolás Gonzalo Núñez, Donatella De Feo, Philipp Kickingereder, Manuel Fischer, Ed Green, Ahmed Sadik, Mirco Friedrich, Khwab Sanghvi, Michael Kilian, Frederik Cichon, Lara Wolf, Kristine Jähne, Anna von Landenberg, Lukas Bunse, Felix Sahm, Daniel Schrimpf, Jochen Meyer, Allen Alexander, Gianluca Brugnara, Ralph Röth, Kira Pfleiderer, Beate Niesler, Andreas von Deimling, Christiane Opitz, Michael O. Breckwoldt, Sabine Heiland, Martin Bendszus, Wolfgang Wick, Burkhard Becher & Michael Platten. (2020) Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nature Communications 11:1.
Crossref
Crossref
Hongxiang Wang, Tao Xu, Qilin Huang, Weilin Jin & Juxiang Chen. (2020) Immunotherapy for Malignant Glioma: Current Status and Future Directions. Trends in Pharmacological Sciences 41:2, pages 123-138.
Crossref
Crossref
Tomoyuki KOGA, Clark C. CHEN & Frank B. FURNARI. (2020) Genome Engineering Evolves Brain Tumor Modeling. Neurologia medico-chirurgica 60:7, pages 329-336.
Crossref
Crossref
Nazanin Majd, Pushan Dasgupta & John de Groot. 2020. Immunotherapy. Immunotherapy
183
203
.
Nazanin Majd, Carlos Kamiya-Matsuoka & John de Groot. (2019) The path forward for anti-programmed cell death-1 therapy in gliomas. Current Opinion in Neurology 32:6, pages 864-871.
Crossref
Crossref
Hans-Georg Wirsching, Huajia Zhang, Frank Szulzewsky, Sonali Arora, Paola Grandi, Patrick J. Cimino, Nduka Amankulor, Jean S. Campbell, Lisa McFerrin, Siobhan S. Pattwell, Chibawanye Ene, Alexandra Hicks, Michael Ball, James Yan, Jenny Zhang, Debrah Kumasaka, Robert H. Pierce, Michael Weller, Mitchell Finer, Christophe Quéva, Joseph C. Glorioso, A. McGarry Houghton & Eric C. Holland. (2019) Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight 4:13.
Crossref
Crossref
Miika Martikainen & Magnus Essand. (2019) Virus-Based Immunotherapy of Glioblastoma. Cancers 11:2, pages 186.
Crossref
Crossref